leadf
logo-loader
ASX:ZLD OTCQB:ZLDAF

Zelira Therapeutics Ltd

Receive alerts
Market:
ASX
Market Cap:
$47.61 m
Price
0.04 AUD
Change
5.26%
52 weeks high
0.14
52 weeks low
0.04

In brief

Zelira Therapeutics Ltd (ASX:ZLD) is a leading global medical cannabis company with access to the world’s largest and fastest-growing cannabis markets.

The company owns a portfolio of proprietary revenue-generating products and has a pipeline of candidates undergoing clinical development that are positioned to enter global markets soon.

Zelira is undertaking product development programs targeting specific conditions and also conducting clinical trial programs focused on insomnia, autism and opioid reduction in patients with chronic non-cancer pain.

Snapshot

It is focused on developing branded cannabis products for a variety of medical conditions and is undertaking product development programs targeting specific conditions and human clinical trial programs focused on insomnia, autism and opioid reduction in patients with chronic non-cancer pain.